Costs of HIV Treatment in Rural China
Author Information
Author(s): Zhou Feng, Kominski Gerald F, Qian Han-Zhu, Wang Jiansheng, Duan Song, Guo Zhiwei, Zhao Xinping
Primary Institution: Institute of Pathogen Biology, Chinese Academy of Medical Science
Hypothesis
What are the actual expenditures and factors influencing costs for untreated AIDS patients in rural China after initiating antiretroviral therapy?
Conclusion
The study found that costs for antiretroviral drugs were the largest part of HIV medical expenditures, and starting treatment at higher CD4 cell counts can reduce overall treatment costs.
Supporting Evidence
- 85% of total expenditure was spent on ARV medications.
- Patients with lower CD4 counts had higher treatment costs.
- Initiating HAART at higher CD4 counts can reduce treatment expenses.
Takeaway
This study looked at how much it costs to treat people with HIV in rural China, finding that starting treatment earlier can save money.
Methodology
A retrospective cohort study was conducted, collecting data from medical records and prescriptions at local hospitals.
Potential Biases
Potential bias due to the selection of study sites and the retrospective nature of the data collection.
Limitations
The results may not be applicable to all of China due to regional cost differences and the study's focus on specific provinces.
Participant Demographics
276 patients, average age 39 years, 62% male, 71% married, diverse ethnic backgrounds including Han and Jingpo.
Statistical Information
P-Value
p<0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website